PackTalk is a blog for the Healthcare Packaging Industry

Eli Lilly Starts Human Study of Potential COVID-19 Antibody Test


Published on June 4, 2020

Companies and research institutions around the world are racing to find a viable treatment for COVID-19, which has already caused ~370,000 deaths worldwide and continues to rise. Eli Lilly recently announced their progress, and are moving into the human study portion of their antibody treatment. They have developed this treatment from a blood sample that was taken from one of the first patients in the United States to have recovered from the lung illness caused by COVID-19. 

Eli Lilly is anticipating results to their study by end of June. Read more about the treatment here.


Comments (0)

Related Articles

The Colors in Medical Packaging

January 31, 2023

Red, orange, yellow, green, blue, indigo, violet – ROY G BIV. This popular acronym started as a way to identify a common color sequence, like that of a rainbow. And it’s the varying shades of these colors that change the way we see the world each day; from...

Learn More

Happy New Year: May It Be Lucky for All of Us!

January 31, 2023

Happy Lunar New Year, from our team to yours! Around the world, more than two billion people celebrate the holiday. 2023 is the year of the rabbit (in Vietnam, the rabbit is replaced by a cat). In Chinese culture, the rabbit is known as the luckiest out of...

Learn More

The 4 Pillars of Packaging Validation

January 31, 2023

In the world of medical devices and healthcare packaging, patient safety is the top priority, and a key reason why those of us in the industry do what we do every day. For terminally sterilized products, packaging is a primary contribution to the sterile...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.